Trendlines

Non-IFRS value of the portfolio at the end of June 2023 was US$152.8 million

Trendlines promotes responsible and ethical operations among all its portfolio companies.

"We believe that our company is undervalued by the market."

Trendlines Medical Singapore and National Healthcare Group renew three-year MOU

SINGAPORE (Nov 27): NRA Capital has found 11 “hidden gems” within Trendlines’ portfolio and derived a higher valuation of US$139 million ($187 million) or 22.5 cents per share.

SINGAPORE (Aug 7): Trendlines, the investor, incubator and developer of early-stage, high-medical and agricultural technology companies in Israel, has reported 2Q earnings of US$2.4 million compared to a loss of US$4.6 million a year ago.

SINGAPORE (Feb 22): The Trendlines Group, an Israeli-based company focused on developing technology-based companies in the medical and agricultural fields, posted full-year loss of US$6.6 million ($9.4 million), double from its loss of US$3.3 million decl

SINGAPORE (Feb 1): Here are some stocks that could move the market this Wednesday morning.

SINGAPORE (Jan 16): Here are some stocks that could move the market this Monday morning:

SINGAPORE (Dec 21): Trendlines Group has entered an agreement with B. Braun, the German medical device company, for the latter to become a 20.74% minority shareholder in the group’s wholly-owned subsidiary, Trendlines Medical Singapore.